HCaRG/COMMD5 inhibits ErbB receptor-driven renal cell carcinoma.
Matsuda H, Campion CG, Fujiwara K, Ikeda J, Cossette S, Verissimo T, Ogasawara M, Gaboury L, Saito K, Yamaguchi K, Takahashi S, Endo M, Fukuda N, Soma M, Hamet P, Tremblay J.
Matsuda H, et al. Among authors: soma m.
Oncotarget. 2017 May 19;8(41):69559-69576. doi: 10.18632/oncotarget.18012. eCollection 2017 Sep 19.
Oncotarget. 2017.
PMID: 29050225
Free PMC article.